+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cardiac Biomarkers Testing Market (2019-2025)

  • ID: 4801485
  • Report
  • Region: Global
  • 250 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Johnson and Johnson
  • Quidel Corporation
  • Siemens AG
  • MORE
The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.

Cardiac biomarkers or cardiac markers are endogenous substances which are released in the blood stream when the heart is damaged or stressed. The acute coronary syndrome is caused by a plaque formed due to atherosclerosis, which causes thrombus formation in the damaged coronary artery and results in a sudden decrease in the amount of blood and oxygen which reaches the heart. Angina is due to the reduced blood supply in the heart, and when such blood flow is interrupted for 30–60 min, it can cause necrosis of heart muscle, resulting in myocardial infarction.

The recent product launches and further developments in the products are major growth trends which are providing lucrative growth opportunities to the cardiac biomarker market. The rising demand for efficient and rapid diagnostics of cardiovascular diseases is the key contributing factor to sector growth. Alere triage panel, manufactured by Alere, Inc., is a combination of three major biomarkers namely, CK-MB, myoglobin, and troponin I. The test is handy due to efficient detection of the cardiovascular disease and, being a combination product, there is a great demand for the test in the market.

Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. The PoC testing segment is projected to witness growth at the highest CAGR during the forecast period. The rising demand for the PoC segment has led to the growth of the segment. Moreover, the rising awareness in the developing countries regarding the use of PoC testing and its application in cardiac biomarkers has nurtured the market growth. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Scope of the Study

Market Segmentation:

By Type
  • Creatine Kinase (CK-MB)
  • Troponins
  • Myoglobin
  • Natriuretic Peptides (BNP and NT-proBNP)
  • Ischemia Modified Albumin
  • Others
By Application
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others
By Location of Testing
  • Point of Care Testing
  • Laboratory Testing
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Johnson and Johnson
  • Quidel Corporation
  • Siemens AG
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cardiac Biomarkers Testing Market, by Type
1.4.2 Global Cardiac Biomarkers Testing Market, by Application
1.4.3 Global Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 Global Cardiac Biomarkers Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint

Chapter 3. Global Cardiac Biomarkers Testing Market by Type
3.1.1 Global Creatine Kinase (CK-MB) Market by Region
3.1.2 Global Troponins Market by Region
3.1.3 Global Myoglobin Market by Region
3.1.4 Global Natriuretic Peptides (BNP and NT-proBNP) Market by Region
3.1.5 Global Ischemia Modified Albumin Market by Region
3.1.6 Global Others Market by Region

Chapter 4. Global Cardiac Biomarkers Testing Market by Application
4.1.1 Global Myocardial Infarction Market by Region
4.1.2 Global Congestive Heart Failure Market by Region
4.1.3 Global Acute Coronary Syndrome Market by Region
4.1.4 Global Atherosclerosis Market by Region
4.1.5 Global Others Market by Region

Chapter 5. Global Cardiac Biomarkers Testing Market by Location of Testing
5.1.1 Global Point of Care Testing Market by Region
5.1.2 Global Laboratory Testing Market by Region

Chapter 6. Global Cardiac Biomarkers Testing Market by Region
6.1 North America Cardiac Biomarkers Testing Market
6.1.1 North America Cardiac Biomarkers Testing Market by Type
6.1.1.1 North America Creatine Kinase (CK-MB) Market by Country
6.1.1.2 North America Troponins Market by Country
6.1.1.3 North America Myoglobin Market by Country
6.1.1.4 North America Natriuretic Peptides (BNP and NT-proBNP) Market by Country
6.1.1.5 North America Ischemia Modified Albumin Market by Country
6.1.1.6 North America Others Market by Country
6.1.2 North America Cardiac Biomarkers Testing Market by Application
6.1.2.1 North America Myocardial Infarction Market by Country
6.1.2.2 North America Congestive Heart Failure Market by Country
6.1.2.3 North America Acute Coronary Syndrome Market by Country
6.1.2.4 North America Atherosclerosis Market by Country
6.1.2.5 North America Others Market by Country
6.1.3 North America Cardiac Biomarkers Testing Market by Location of Testing
6.1.3.1 North America Point of Care Testing Market by Country
6.1.3.2 North America Laboratory Testing Market by Country
6.1.4 North America Cardiac Biomarkers Testing Market by Country
6.1.4.1 USA Cardiac Biomarkers Testing Market
6.1.4.1.1 USA Cardiac Biomarkers Testing Market by Type
6.1.4.1.2 USA Cardiac Biomarkers Testing Market by Application
6.1.4.1.3 USA Cardiac Biomarkers Testing Market by Location of Testing
6.1.4.2 Canada Cardiac Biomarkers Testing Market
6.1.4.2.1 Canada Cardiac Biomarkers Testing Market by Type
6.1.4.2.2 Canada Cardiac Biomarkers Testing Market by Application
6.1.4.2.3 Canada Cardiac Biomarkers Testing Market by Location of Testing
6.1.4.3 Mexico Cardiac Biomarkers Testing Market
6.1.4.3.1 Mexico Cardiac Biomarkers Testing Market by Type
6.1.4.3.2 Mexico Cardiac Biomarkers Testing Market by Application
6.1.4.3.3 Mexico Cardiac Biomarkers Testing Market by Location of Testing
6.1.4.4 Rest of North America Cardiac Biomarkers Testing Market
6.1.4.4.1 Rest of North America Cardiac Biomarkers Testing Market by Type
6.1.4.4.2 Rest of North America Cardiac Biomarkers Testing Market by Application
6.1.4.4.3 Rest of North America Cardiac Biomarkers Testing Market by Location of Testing
6.2 Europe Cardiac Biomarkers Testing Market
6.2.1 Europe Cardiac Biomarkers Testing Market by Type
6.2.1.1 Europe Creatine Kinase (CK-MB) Market by Country
6.2.1.2 Europe Troponins Market by Country
6.2.1.3 Europe Myoglobin Market by Country
6.2.1.4 Europe Natriuretic Peptides (BNP and NT-proBNP) Market by Country
6.2.1.5 Europe Ischemia Modified Albumin Market by Country
6.2.1.6 Europe Others Market by Country
6.2.2 Europe Cardiac Biomarkers Testing Market by Application
6.2.2.1 Europe Myocardial Infarction Market by Country
6.2.2.2 Europe Congestive Heart Failure Market by Country
6.2.2.3 Europe Acute Coronary Syndrome Market by Country
6.2.2.4 Europe Atherosclerosis Market by Country
6.2.2.5 Europe Others Market by Country
6.2.3 Europe Cardiac Biomarkers Testing Market by Location of Testing
6.2.3.1 Europe Point of Care Testing Market by Country
6.2.3.2 Europe Laboratory Testing Market by Country
6.2.4 Europe Cardiac Biomarkers Testing Market by Country
6.2.4.1 Germany Cardiac Biomarkers Testing Market
6.2.4.1.1 Germany Cardiac Biomarkers Testing Market by Type
6.2.4.1.2 Germany Cardiac Biomarkers Testing Market by Application
6.2.4.1.3 Germany Cardiac Biomarkers Testing Market by Location of Testing
6.2.4.2 UK Cardiac Biomarkers Testing Market
6.2.4.2.1 UK Cardiac Biomarkers Testing Market by Type
6.2.4.2.2 UK Cardiac Biomarkers Testing Market by Application
6.2.4.2.3 UK Cardiac Biomarkers Testing Market by Location of Testing
6.2.4.3 France Cardiac Biomarkers Testing Market
6.2.4.3.1 France Cardiac Biomarkers Testing Market by Type
6.2.4.3.2 France Cardiac Biomarkers Testing Market by Application
6.2.4.3.3 France Cardiac Biomarkers Testing Market by Location of Testing
6.2.4.4 Russia Cardiac Biomarkers Testing Market
6.2.4.4.1 Russia Cardiac Biomarkers Testing Market by Type
6.2.4.4.2 Russia Cardiac Biomarkers Testing Market by Application
6.2.4.4.3 Russia Cardiac Biomarkers Testing Market by Location of Testing
6.2.4.5 Spain Cardiac Biomarkers Testing Market
6.2.4.5.1 Spain Cardiac Biomarkers Testing Market by Type
6.2.4.5.2 Spain Cardiac Biomarkers Testing Market by Application
6.2.4.5.3 Spain Cardiac Biomarkers Testing Market by Location of Testing
6.2.4.6 Italy Cardiac Biomarkers Testing Market
6.2.4.6.1 Italy Cardiac Biomarkers Testing Market by Type
6.2.4.6.2 Italy Cardiac Biomarkers Testing Market by Application
6.2.4.6.3 Italy Cardiac Biomarkers Testing Market by Location of Testing
6.2.4.7 Rest of Europe Cardiac Biomarkers Testing Market
6.2.4.7.1 Rest of Europe Cardiac Biomarkers Testing Market by Type
6.2.4.7.2 Rest of Europe Cardiac Biomarkers Testing Market by Application
6.2.4.7.3 Rest of Europe Cardiac Biomarkers Testing Market by Location of Testing
6.3 Asia Pacific Cardiac Biomarkers Testing Market
6.3.1 Asia Pacific Cardiac Biomarkers Testing Market by Type
6.3.1.1 Asia Pacific Creatine Kinase (CK-MB) Market by Country
6.3.1.2 Asia Pacific Troponins Market by Country
6.3.1.3 Asia Pacific Myoglobin Market by Country
6.3.1.4 Asia Pacific Natriuretic Peptides (BNP and NT-proBNP) Market by Country
6.3.1.5 Asia Pacific Ischemia Modified Albumin Market by Country
6.3.1.6 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Cardiac Biomarkers Testing Market by Application
6.3.2.1 Asia Pacific Myocardial Infarction Market by Country
6.3.2.2 Asia Pacific Congestive Heart Failure Market by Country
6.3.2.3 Asia Pacific Acute Coronary Syndrome Market by Country
6.3.2.4 Asia Pacific Atherosclerosis Market by Country
6.3.2.5 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
6.3.3.1 Asia Pacific Point of Care Testing Market by Country
6.3.3.2 Asia Pacific Laboratory Testing Market by Country
6.3.4 Asia Pacific Cardiac Biomarkers Testing Market by Country
6.3.4.1 China Cardiac Biomarkers Testing Market
6.3.4.1.1 China Cardiac Biomarkers Testing Market by Type
6.3.4.1.2 China Cardiac Biomarkers Testing Market by Application
6.3.4.1.3 China Cardiac Biomarkers Testing Market by Location of Testing
6.3.4.2 Japan Cardiac Biomarkers Testing Market
6.3.4.2.1 Japan Cardiac Biomarkers Testing Market by Type
6.3.4.2.2 Japan Cardiac Biomarkers Testing Market by Application
6.3.4.2.3 Japan Cardiac Biomarkers Testing Market by Location of Testing
6.3.4.3 India Cardiac Biomarkers Testing Market
6.3.4.3.1 India Cardiac Biomarkers Testing Market by Type
6.3.4.3.2 India Cardiac Biomarkers Testing Market by Application
6.3.4.3.3 India Cardiac Biomarkers Testing Market by Location of Testing
6.3.4.4 South Korea Cardiac Biomarkers Testing Market
6.3.4.4.1 South Korea Cardiac Biomarkers Testing Market by Type
6.3.4.4.2 South Korea Cardiac Biomarkers Testing Market by Application
6.3.4.4.3 South Korea Cardiac Biomarkers Testing Market by Location of Testing
6.3.4.5 Singapore Cardiac Biomarkers Testing Market
6.3.4.5.1 Singapore Cardiac Biomarkers Testing Market by Type
6.3.4.5.2 Singapore Cardiac Biomarkers Testing Market by Application
6.3.4.5.3 Singapore Cardiac Biomarkers Testing Market by Location of Testing
6.3.4.6 Malaysia Cardiac Biomarkers Testing Market
6.3.4.6.1 Malaysia Cardiac Biomarkers Testing Market by Type
6.3.4.6.2 Malaysia Cardiac Biomarkers Testing Market by Application
6.3.4.6.3 Malaysia Cardiac Biomarkers Testing Market by Location of Testing
6.3.4.7 Rest of Asia Pacific Cardiac Biomarkers Testing Market
6.3.4.7.1 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Type
6.3.4.7.2 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Application
6.3.4.7.3 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
6.4 LAMEA Cardiac Biomarkers Testing Market
6.4.1 LAMEA Cardiac Biomarkers Testing Market by Type
6.4.1.1 LAMEA Creatine Kinase (CK-MB) Market by Country
6.4.1.2 LAMEA Troponins Market by Country
6.4.1.3 LAMEA Myoglobin Market by Country
6.4.1.4 LAMEA Natriuretic Peptides (BNP and NT-proBNP) Market by Country
6.4.1.5 LAMEA Ischemia Modified Albumin Market by Country
6.4.1.6 LAMEA Others Market by Country
6.4.2 LAMEA Cardiac Biomarkers Testing Market by Application
6.4.2.1 LAMEA Myocardial Infarction Market by Country
6.4.2.2 LAMEA Congestive Heart Failure Market by Country
6.4.2.3 LAMEA Acute Coronary Syndrome Market by Country
6.4.2.4 LAMEA Atherosclerosis Market by Country
6.4.2.5 LAMEA Others Market by Country
6.4.3 LAMEA Cardiac Biomarkers Testing Market by Location of Testing
6.4.3.1 LAMEA Point of Care Testing Market by Country
6.4.3.2 LAMEA Laboratory Testing Market by Country
6.4.4 LAMEA Cardiac Biomarkers Testing Market by Country
6.4.4.1 Brazil Cardiac Biomarkers Testing Market
6.4.4.1.1 Brazil Cardiac Biomarkers Testing Market by Type
6.4.4.1.2 Brazil Cardiac Biomarkers Testing Market by Application
6.4.4.1.3 Brazil Cardiac Biomarkers Testing Market by Location of Testing
6.4.4.2 Argentina Cardiac Biomarkers Testing Market
6.4.4.2.1 Argentina Cardiac Biomarkers Testing Market by Type
6.4.4.2.2 Argentina Cardiac Biomarkers Testing Market by Application
6.4.4.2.3 Argentina Cardiac Biomarkers Testing Market by Location of Testing
6.4.4.3 UAE Cardiac Biomarkers Testing Market
6.4.4.3.1 UAE Cardiac Biomarkers Testing Market by Type
6.4.4.3.2 UAE Cardiac Biomarkers Testing Market by Application
6.4.4.3.3 UAE Cardiac Biomarkers Testing Market by Location of Testing
6.4.4.4 Saudi Arabia Cardiac Biomarkers Testing Market
6.4.4.4.1 Saudi Arabia Cardiac Biomarkers Testing Market by Type
6.4.4.4.2 Saudi Arabia Cardiac Biomarkers Testing Market by Application
6.4.4.4.3 Saudi Arabia Cardiac Biomarkers Testing Market by Location of Testing
6.4.4.5 South Africa Cardiac Biomarkers Testing Market
6.4.4.5.1 South Africa Cardiac Biomarkers Testing Market by Type
6.4.4.5.2 South Africa Cardiac Biomarkers Testing Market by Application
6.4.4.5.3 South Africa Cardiac Biomarkers Testing Market by Location of Testing
6.4.4.6 Nigeria Cardiac Biomarkers Testing Market
6.4.4.6.1 Nigeria Cardiac Biomarkers Testing Market by Type
6.4.4.6.2 Nigeria Cardiac Biomarkers Testing Market by Application
6.4.4.6.3 Nigeria Cardiac Biomarkers Testing Market by Location of Testing
6.4.4.7 Rest of LAMEA Cardiac Biomarkers Testing Market
6.4.4.7.1 Rest of LAMEA Cardiac Biomarkers Testing Market by Type
6.4.4.7.2 Rest of LAMEA Cardiac Biomarkers Testing Market by Application
6.4.4.7.3 Rest of LAMEA Cardiac Biomarkers Testing Market by Location of Testing

Chapter 7. Company Profiles
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
Note: Product cover images may vary from those shown
Adroll
adroll